WongABenedictNJArmahizerMJKane-GillSL. Evaluation of adjunctive ketamine to benzodiazepines for management of alcohol withdrawal syndrome. Ann Pharmacother. 2015;49:14-19.
2.
RaynerSGWeinertCRPengHJepsenSBroccardAF. Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU. Ann Intensive Care. 2012;2:12.
3.
DeMuroJPBotrosDGWirkowskiEHannaAF. Use of dexmedetomidine for the treatment of alcohol withdrawal in critically ill patients: a retrospective case series. J Anesth. 2012;26:601-605.
4.
FrazeeENPersonettHALeungJGNelsonSDierkhisingRABauerPR. Influence of dexmedetomidine therapy on the management of severe alcohol withdrawal syndrome in critically ill patients. J Crit Care. 2014;29:298-302.
5.
CrispoALDaleyMJPepinJLHarfordPHBrownCV. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous infusion sedatives: dexmedetomidine versus benzodiazepines. Pharmacotherapy. 2014;34:910-917.
6.
HaynerCEWuestefieldNLBoltonPJ. Phenobarbital treatment in a patient with resistant alcohol withdrawal syndrome. Pharmacotherapy. 2009;29:875-878.
7.
LorentzenKLauritsenAOBendtsenAO. Use of propofol infusion in alcohol withdrawal-induced refractory delirium tremens. Dan Med J. 2014;61:A4807.
8.
RosensonJClementsCSimonB. Phenobarbital for acute alcohol withdrawal: a prospective randomized double-blind placebo-controlled study. J Emerg Med. 2013;44:592-598.
9.
DubyJJBerryAJGhayyenPWilsonMDCocanourCS. Alcohol withdrawal syndrome in critically ill patients: protocolized versus nonprotocolized management. J Trauma Acute Care Surg. 2014;77:938-943.
